Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation

被引：0
|
作者：
Felix Korell
Zachariah DeFilipp
Nicholas Schreck
Thomas Luft
机构：
[1] University Hospital Heidelberg,Department of Hematology and Oncology
[2] Massachusetts General Hospital Cancer Center,Hematopoietic Cell Transplant and Cellular Therapy Program
[3] German Cancer Research Center,Division of Biostatistics
来源：
Intensive Care Medicine | 2023年 / 49卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1408 / 1410
页数：2
相关论文
共 50 条
  • [41] Neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation
    Barba, P.
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Sureda, A.
    Delgado, J.
    Briones, J.
    Brunet, S.
    Sierra, J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S72 - S73
  • [42] Study of recombinant erythropoietin after reduced intensity conditioning for allogeneic stem cell transplantation
    Ivanov, V
    Faucher, C
    Ladaique, P
    Bilger, K
    Mohty, M
    Sainty, D
    Chabannon, C
    Vey, N
    Maraninchi, D
    Blaise, D
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S147 - S147
  • [43] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    Sureda, A
    Schmitz, N
    [J]. ANNALS OF HEMATOLOGY, 2003, 82 (01) : 1 - 13
  • [44] It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)
    Luft, Thomas
    Benner, Axel
    Jodele, Sonata
    Dandoy, Christopher E.
    Storb, Rainer F.
    Gooley, Ted A.
    Sandmaier, Brenda M.
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Penack, Olaf
    [J]. BLOOD, 2016, 128 (22)
  • [45] Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation
    Zenz, T
    Schlenk, RF
    Glatting, G
    Neumaier, B
    Blumstein, N
    Buchmann, I
    von Harsdorf, S
    Ringhoffer, M
    Wiesneth, M
    Keller, F
    Kotzerke, J
    Röttinger, E
    Stilgenbauer, S
    Döhner, H
    Reske, SN
    Bunjes, D
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (02) : 278 - 286
  • [46] Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
    Saha, Asim
    Blazar, Bruce R.
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [48] Second allogeneic stem cell transplantation for osteomyelofibrosis relapsed after initial allogeneic stem cell transplantation
    Klyuchnikov, E.
    Ayuk, F.
    Bacher, U.
    Zander, A.
    Kroeger, N.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S262 - S262
  • [49] Outcome prediction after allogeneic stem cell transplantation: the doctor's perspective
    Schetelig, J.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S562 - S562
  • [50] Early Experience with Clofarabine Pre-Conditioning Prior to Full Intensity or Reduced Toxicity Allogeneic Stem Cell Transplantation: A Promising New Therapy for the Treatment of Refractory Acute Leukaemia
    Richardson, Deborah S.
    Publicover, Amy
    Hill, Kate
    Hurlock, Carol
    Newman, Joan
    McKeag, Nikki
    Main, Sara
    Launders, Harriet
    Orchard, Kim H.
    [J]. BLOOD, 2012, 120 (21)
12345